DANAZOL
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | DANAZOL |
| DrugBank ID | DB01406 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 9 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| postmenopausal osteoporosis | TxGNN Knowledge Graph | L5 |
| osteoporosis | TxGNN Knowledge Graph | L5 |
| premature menopause | TxGNN Knowledge Graph | L5 |
| hypogonadism, male | TxGNN Knowledge Graph | L5 |
| androgen insensitivity syndrome | TxGNN Knowledge Graph | L5 |
| eunuchism | TxGNN Knowledge Graph | L5 |
| obsolete atrophic vulva | TxGNN Knowledge Graph | L5 |
| acne (disease) | TxGNN Knowledge Graph | L5 |
| postmenopausal atrophic vaginitis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11